Your browser doesn't support javascript.
loading
Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
Clinical Psychopharmacology and Neuroscience ; : 221-223, 2018.
Article in English | WPRIM | ID: wpr-714646
ABSTRACT
Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Psychotic Disorders / Antipsychotic Agents / Spinocerebellar Degenerations / Myoclonic Epilepsies, Progressive Limits: Adult / Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Psychotic Disorders / Antipsychotic Agents / Spinocerebellar Degenerations / Myoclonic Epilepsies, Progressive Limits: Adult / Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2018 Type: Article